跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 300 条关于
“chemoimmunotherapy”
全部
300
临床试验
186
药物
0
机构
0
资讯
114
去年
Induction Chemoimmunotherapy Shows Promise in Unresectable Stage III NSCLC Treatment
去年
Chemoimmunotherapy Combines With Checkpoint Inhibitors to Improve NSCLC Treatment
去年
AMPLIFY Trial Shows Promise: Acalabrutinib Combinations Outperform Chemoimmunotherapy in CLL/SLL Treatment
去年
Induction Chemoimmunotherapy Shows Non-Inferior Outcomes to Consolidation Therapy in Stage III NSCLC
去年
Chemoimmunotherapy Shows Limited Efficacy in Younger Patients with Extensive-Stage Small Cell Lung Cancer
2年前
CALQUENCE Plus Chemoimmunotherapy Shows 27% Reduction in Disease Progression Risk for Untreated Mantle Cell Lymphoma
2个月前
KEYNOTE-966 Long-Term Follow-Up Confirms Durable Survival Benefit and Manageable Safety of Pembrolizumab Chemoimmunotherapy
去年
AMPLIFY Trial: Acalabrutinib and Venetoclax Show Promise in Treatment-Naive CLL
去年
Calquence Plus Venetoclax Shows Superior PFS in Untreated CLL
去年
Calquence Plus Venetoclax Shows Promise in Front-Line CLL Treatment
第 1 页,共 12 页
上一页
下一页